Boston Scientific is infusing medical device company Millipede with $90 million, an equity investment that comes with the option to acquire the startup outright. According to the agreement, Marlborough, MA-based Boston Scientific (NYSE: BSX) must exercise its option to acquire Millipede before the startup completes its ongoing clinical trial for its heart valve repair device—as […]